Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Mar 03,2016
Medicilon Animal Studies CRO Services
Medicilon is a company engaged in pre-clinical research outsourcing services (CRO), which specializes in providing customers with customizable pre-clinical trial service programs. Professional knowledge in pharmacodynamic research and toxicology. Provide you with high-quality data and fast turnaround to support various drug development, preclinical research and clinical research. Help you select the most valuable drug candidatesRead more
More
Medicilon Animal Studies CRO Services
Mar 02,2016
First Malaria Vaccine Trial In Humans
    While the deaths from malaria are devastating, ranging in the hundreds of thousands annually, it is often the morbidity associated with this parasitic infection that can be viewed as even worse—decimating large populations and incapacitating members within endemic areas who are critical to its economic vitality. There are five different species of malaria parasites thatRead more
More
Mar 02,2016
Glucose In, Heart Disease Out
    Coronary artery disease (CAD) accounts for nearly half of all deaths in the United States and arises when blood flow through the arteries that supply oxygen-rich blood to the heart is impaired. The underlying process—the buildup of plaque inside the arteries—is called atherosclerosis.     “Most of us develop arterial plaque over the course of our lifetimes,”Read more
More
Mar 01,2016
Specific Proteins Found to Jump Start Spread of Cancer Cells
    Scientists at the University of California, San Diego School of Medicine and Moores Cancer Center, with colleagues in Spain and Germany, have discovered how elevated levels of particular proteins in cancer cells trigger hyperactivity in other proteins, fueling the growth and spread of a variety of cancers. Their study (“Prognostic Impact of Modulators of GRead more
More
Mar 01,2016
Genetically Engineered E. coli Cranks Out Opiate Precursor
    Though opiate drug use has been much maligned over the past several years, the need for medically relevant painkillers has not waned. Scientists have been continually on the hunt for improved production methods of opiate compounds, as extraction from poppy sap is inefficient and time-consuming.     Now, a team of Japanese researchers from Ishikawa Prefectural UniversityRead more
More
Feb 29,2016
Researchers Make Groundbreaking Discovery, Using Skin Cells to Kill Cancer
    In a new landmark study, pharmacy researchers from the University of North Carolina at Chapel Hill turn skin cells into cancer-hunting stem cells that destroy brain tumors know as glioblastoma. The investigators are optimistic that this technique could provide a significantly more effective treatment for the disease, which typically has a poor long-term survival rate.Read more
More
Feb 29,2016
Squishy Embryos Might Be The Most Viable
    Only about 30 percent of embryos implanted for in-vitro fertilization result in the birth of a healthy baby. One of the reasons IVF might fail is that the embryo (or embryos) that the doctors implant into the prospective mother might not stand the best chance for healthy development.      Now scientists from Stanford University believe they have foundRead more
More
Feb 26,2016
Installing Smartly Formulated Receptors Improves Function of Diseased Hearts
    A designer protein has been used to enhance cardiac contractility and alleviate heart disease, and the protein, a customized version of a Ca2+-sensitive receptor called Troponin C, is effective even if it is introduced in fairly modest degrees. The success of the customized Troponin C suggests that designer proteins, in combination with gene therapy, mayRead more
More
Feb 26,2016
Transforming Molecular Diagnostic Point of Care with Cell Phones
    Scientists at Caltech report that they have invented a new technique that can help bring emerging diagnostic capabilities out of laboratories and to the point of care. To address the need for a robust readout system for quantitative diagnostics, the researchers devised a novel visual readout method that uses analytical chemistries and image processing toRead more
More
Feb 25,2016
Whole Genome Study Allays Cancer Fears Surrounding Stem Cell Techniques
    Cell-replacement therapies that depend on induced pluripotent stem cells (iPSCs) inspire hope and fear—hope that cells derived from iPSCs will actualize regenerative medicine; fear that the very same cells will bring cancer-causing mutations to patients. The fear lingers even though several studies have already suggested that iPSCs can be considered safe. These studies were conductedRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->